🔗 Share this article

An underground market for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these accounts directly for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with thousands of members share comparison photos, injection guides and assertions of next-day UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Experts Voice Worries

However, physicians and pharmacists have warned that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could lead to users injecting substances of unknown origin.

Some experts said the demand for retatrutide could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the British medical regulations.

Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and consumer regulations, risking penalties, legal action or prison.

Platform Response and Material Elimination

Based on TikTok, the service has removed violative content and prohibited associated hashtags and search suggestions. The organization stated it was committed to keeping the platform safe and investing in enhancing compliance measures.

Digital Marketplace Operations

Research also found groups with up to 9,000 members selling the experimental drug using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with numerous of members, filled with images of weight loss, positive reviews and step-by-step guides for preparing or administering at home.

After minutes of joining one community, a seller shared WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and promised delivery within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.

Item Details and Costs

Within these communities, messages show black plastic packages with postal service labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or pre-filled injectors typically priced at £160 for 20 milligrams. When asked how much time a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for Telegram said it actively monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they can’t verify. Although the research behind retatrutide is sound, these digital versions may not include what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the surge in interest to current price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are using social media. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her staff has already encountered patients harmed by personal administration from unverified sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental product not yet approved … may expose users to potentially significant health risks”.